89bio (ETNB) Short Interest Ratio & Short Volume → The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad) Free ETNB Stock Alerts $9.03 -0.34 (-3.63%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media 89bio Short Interest DataCurrent Short Volume11,210,000 sharesPrevious Short Volume11,550,000 sharesChange Vs. Previous Month-2.94%Dollar Volume Sold Short$106.38 millionShort Interest Ratio / Days to Cover8.9Last Record DateApril 15, 2024Outstanding Shares95,220,000 sharesPercentage of Shares Shorted11.77%Today's Trading Volume553,058 sharesAverage Trading Volume1,168,311 sharesToday's Volume Vs. Average47% Short Selling 89bio ? Sign up to receive the latest short interest report for 89bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatETNB Short Interest Over TimeETNB Days to Cover Over TimeETNB Percentage of Float Shorted Over Time Ad InvestorPlace$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details. 89bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202411,210,000 shares $106.38 million -2.9%N/A8.9 $9.49 3/31/202411,550,000 shares $134.44 million +4.0%N/A8.8 $11.64 3/15/202411,110,000 shares $150.21 million +2.3%N/A8.2 $13.52 2/29/202410,860,000 shares $124.56 million +2.7%N/A7.6 $11.47 2/15/202410,580,000 shares $103.58 million +9.9%N/A7.8 $9.79 1/31/20249,630,000 shares $95.34 million +7.2%N/A7.1 $9.90 Get the Latest News and Ratings for ETNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 89bio and its competitors with MarketBeat's FREE daily newsletter. 1/15/20248,980,000 shares $99.59 million +5.9%N/A6.7 $11.09 12/31/20238,480,000 shares $94.72 million +24.5%N/A4.9 $11.17 12/15/20236,810,000 shares $72.19 million +12.0%N/A3.9 $10.60 11/30/20236,080,000 shares $48.88 million +0.7%N/A3.6 $8.04 11/15/20236,040,000 shares $45.96 million +11.2%N/A3.9 $7.61 10/31/20235,430,000 shares $40.18 million -19.1%N/A3.7 $7.40 10/15/20236,710,000 shares $51.13 million +6.0%N/A4.7 $7.62 9/30/20236,330,000 shares $97.74 million +7.5%N/A5.6 $15.44 9/15/20235,890,000 shares $102.25 million -6.4%N/A5.7 $17.36 8/31/20236,290,000 shares $107.81 million -28.4%N/A5.3 $17.14 8/15/20238,780,000 shares $147.07 million +9.5%N/A6.9 $16.75 7/31/20238,020,000 shares $127.04 million -11.2%N/A6 $15.84 7/15/20239,030,000 shares $164.80 million -5.0%N/A6.7 $18.25 6/30/20239,500,000 shares $180.03 million +36.5%N/A6.6 $18.95 6/15/20236,960,000 shares $144.00 million -2.3%N/A4 $20.69 5/31/20237,120,000 shares $129.80 million -1.4%N/A3.2 $18.23 5/15/20237,220,000 shares $129.02 million -4.4%N/A3.3 $17.87 4/30/20237,550,000 shares $120.65 million -1.2%N/A3.4 $15.98 4/15/20237,640,000 shares $118.57 million -5.1%N/A3.5 $15.52 3/31/20238,050,000 shares $122.60 million +44.0%N/A3.9 $15.23 3/15/20235,590,000 shares $71.50 million +8.5%N/A2.9 $12.79 2/28/20235,150,000 shares $70.14 million +10.8%N/A4.8 $13.62 2/15/20234,650,000 shares $60.45 million No ChangeN/A4.5 $13.00 1/31/20234,650,000 shares $54.31 million +8.6%N/A4.8 $11.68 1/15/20234,280,000 shares $44.94 million -3.4%N/A4.8 $10.50 12/30/20224,430,000 shares $56.39 million -7.1%N/A4.9 $12.73 12/15/20224,770,000 shares $49.37 million +30.3%N/A5.3 $10.35 11/30/20223,660,000 shares $29.28 million No ChangeN/A2.7 $8.00 11/15/20223,660,000 shares $35.83 million -0.3%N/A2.8 $9.79 10/31/20223,670,000 shares $35.05 million -3.2%N/A2.8 $9.55 10/15/20223,790,000 shares $29.07 million +28.0%N/A3 $7.67 9/30/20222,960,000 shares $17.14 million -6.0%N/A2.6 $5.79 9/15/20223,150,000 shares $18.43 million +55.2%N/A2.7 $5.85 8/31/20222,030,000 shares $9.05 million +1.0%N/A4.2 $4.46READ THIS – If You Missed Out On The AI Boom (Ad)Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. ETNB Short Interest - Frequently Asked Questions What is 89bio's current short interest? Short interest is the volume of 89bio shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 11,210,000 shares of ETNB short. Learn More on 89bio's current short interest. What is a good short interest ratio for 89bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ETNB shares currently have a short interest ratio of 9.0. Learn More on 89bio's short interest ratio. Is 89bio's short interest increasing or decreasing? 89bio saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 11,210,000 shares, a drop of 2.9% from the previous total of 11,550,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does 89bio's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to 89bio: Praxis Precision Medicines, Inc. (4.69%), OPKO Health, Inc. (23.81%), ALX Oncology Holdings Inc. (13.47%), Zentalis Pharmaceuticals, Inc. (23.43%), Arcutis Biotherapeutics, Inc. (17.02%), ARS Pharmaceuticals, Inc. (14.44%), ABIVAX Société Anonyme (0.19%), Ocular Therapeutix, Inc. (9.47%), Immunome, Inc. (4.42%), Tyra Biosciences, Inc. (13.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short 89bio stock? Short selling ETNB is an investing strategy that aims to generate trading profit from 89bio as its price is falling. ETNB shares are trading down $0.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 89bio? A short squeeze for 89bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ETNB, which in turn drives the price of the stock up even further. How often is 89bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ETNB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Praxis Precision Medicines Short Interest OPKO Health Short Interest ALX Oncology Short Interest Zentalis Pharmaceuticals Short Interest Arcutis Biotherapeutics Short Interest ARS Pharmaceuticals Short Interest ABIVAX Société Anonyme Short Interest Ocular Therapeutix Short Interest Immunome Short Interest Tyra Biosciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ETNB) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press